Stocks
IGM Biosciences (IGMS) EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -44.5 | -83.3 | -165.3 | -228.0 | -255.2 | -249.6 | ||
| Changes by years, y/y, % | +98% | +87% | +99% | +38% | +12% | +62.5% | |||
IGM Biosciences. EBITDA US GAAP, bln rub
IGM Biosciences. EBITDA US GAAP, changes, %
IGM Biosciences. EBITDA US GAAP, sum by quarters, bln rub
IGM Biosciences (IGMS) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| EBITDA, bln rub | ? | -61.7 | -66.0 | -66.8 | -62.9 | -53.9 | -249.6 | |
| Changes by years, y/y, % | +22% | +14% | +13% | +12% | -13% | |||
| Changes by quarters, q/q, % | +10% | +7% | +1% | -6% | -14% | |||
